查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1372874

支架市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品類型、生物材料、最終用戶、地區和競爭細分

Stent Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type, By Biomaterial, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 178 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年全球支架市場價值為 100.6 億美元，預計在預測期內將出現令人印象深刻的成長，預計到 2028 年年複合成長率 (CAGR) 為 6.46%。

支架是一種小的網狀管，用於保持體內狹窄或弱化通道（例如動脈）的通暢。它通常用於治療已變窄的冠狀動脈，從而減少對心臟的富氧血液的供應。將支架放置在體內的過程稱為支架置入術。

支架的主要應用之一是恢復因斑塊堆積而阻塞的血管中的血流。這種斑塊通常由血液中的脂肪和膽固醇等物質組成。隨著時間的推移，這種斑塊會黏附在動脈壁上，並逐漸減少到達身體各部位的含氧血液量。斑塊的積聚可導致冠心病的發展。

市場概況
預測期 2024-2028
2022 年市場規模 100.6億美元
2028 年市場規模 147.7億美元
2023-2028 年年複合成長率 6.46%
成長最快的細分市場 醫院和診所
最大的市場 北美洲

有斑塊堆積的人可能會出現警訊，例如胸痛。如果不及時干涉，他們將面臨更高的併發症風險，包括中風或心臟病發作。為了防止動脈阻塞或過度狹窄，醫療保健提供者使用支架來促進不間斷的血液流動。

主要市場促進因素

慢性病盛行率增加

全球慢性病盛行率不斷上升，大大推動了對支架的需求，支架是現代臨床治療的重要組成部分。冠狀動脈疾病、週邊動脈疾病和腎臟疾病等慢性疾病常導致血管變窄，阻礙血液的順暢流動。支架，即用於治療體內狹窄或弱化動脈的小網狀管，為此問題提供了有效的解決方案。

糖尿病和肥胖病例的激增主要是由於久坐的生活方式和不健康的飲食習慣，導致血管疾病的發生率上升。這反過來又推動了支架置入手術的需求。此外，人口老化越來越容易罹患慢性病，這也增加了支架需求的動機。

為了滿足這一不斷成長的需求，醫療器材製造商正在專注於開發先進的支架，其特點是改進的設計、生物相容性和藥物洗脫特性。微創外科手術的進步也促進了這些設備的採用。鑑於支架在應對慢性疾病中發揮的這些不可或缺的作用，預計支架的需求將繼續呈上升趨勢。這使得支架成為全球醫療保健策略的焦點，特別強調提高其有效性、可近性和可負擔性。

老年人口增加

隨著個體年齡的成長，罹患冠狀動脈疾病（CAD）和周邊動脈疾病（PAD）等心血管疾病的風險顯著增加。支架是一種重要的醫療設備，用於透過重新打開阻塞或狹窄的動脈、改善血流並預防心臟病和中風等嚴重併發症來治療這些疾病。老年人經常患有多種慢性健康問題，包括糖尿病和高血壓，這些疾病會加速動脈粥狀硬化的發生和進展。支架經常用於透過保持血管通暢來解決這些病症的後果。支架技術的持續研究和開發催生了更先進和創新的設備。例如，藥物洗脫支架釋放藥物以降低所治療動脈再狹窄或重新狹窄的風險。這些技術進步提高了支架手術的有效性和安全性，使其更適合老年患者。

支架置入通常透過微創手術進行，這通常是可能有其他健康問題的老年患者的首選。與傳統的開放性手術相比，這些手術可以提供更快的恢復時間並減少術後併發症。老年人口的增加是支架需求不斷成長的重要驅動力。隨著老年人更容易患心血管疾病和其他慢性健康狀況，對支架植入等介入手術的需求預計會增加。創新支架技術和微創技術的發展進一步支持支架的利用來滿足老年人的醫療保健需求，最終提高他們的整體生活品質和壽命。

支架開發的技術進步

醫療保健領域對先進技術的需求不斷成長，導致市場對支架的需求大幅增加。隨著越來越多的老年人需要醫療干涉，支架已成為滿足其醫療保健需求的重要組成部分。此外，更高的可支配收入使個人能夠選擇尖端技術和設備，以在外科手術後提供更好的結果。

這些最先進技術的利用增強了潛在消費者的信心，確保他們相信手術程序和技術的有效性和可靠性。這不僅提高了患者滿意度，也有助於支架市場的整體成長。此外，疫情爆發後的最新進展，例如創新支架設計和材料的開發，進一步促進了支架市場的擴張。

這些發展為這一關鍵醫療領域的成長和創新創造了新的機會，為支架技術的進步鋪平了道路，以滿足患者和醫療保健提供者不斷變化的需求。隨著對先進醫療解決方案的需求持續成長，支架市場有望進一步擴大和進步，在改善患者治療效果和提高醫療品質方面發揮著至關重要的作用。

對外科手術的需求不斷增加

近年來，利用微創技術的先進外科手術的需求明顯且逐漸增加。這些尖端方法徹底改變了手術領域，為患者提供了侵入性較小的選擇和更快的恢復時間。特別受益於這些進步的一個領域是心血管外科。現代設備和裝置的引入極大地提高了心血管系統相關外科手術的成功率和結果。特別是支架的使用已變得越來越普遍，為因高膽固醇水平引起的嚴重阻塞的患者提供了有效的解決方案。

老年人口的偏好進一步刺激了對手術介入的需求。由於等待藥物起效的時間有限，許多老年患者選擇外科手術作為治療心血管疾病的更直接的解決方案。對外科手術介入的需求不斷成長，為預測期內的市場成長提供了重大機會。隨著全球患有嚴重心血管疾病的人數持續增加，先進外科手術及相關產品的市場可望長期擴張。總體而言，這些趨勢凸顯了微創手術領域持續創新的必要性以及病患照護和結果顯著進步的潛力。

主要市場挑戰

不利的政府法規

與現代技術發展直接相關的眾多規則和法規嚴重阻礙了支架市場的成長。政府實施的這些法規為市場的擴張帶來了重大挑戰和障礙。不利的政府法規和指導方針不僅在短期內影響了市場，而且從長遠來看也有可能阻礙其成長。

遇到這些障礙的關鍵領域之一是保險範圍。有關支架手術保險範圍的規定使一般民眾難以取得和負擔這些現代技術。此外，稅收負擔進一步增加了尋求支架治療的個人面臨的財務挑戰。由於政府實施的複雜的法規和指導方針，支架市場面臨重大障礙。這些障礙不僅限制了市場的成長潛力，也限制了那些可以從中受益的人獲得現代科技的機會。

高產品召回率

由於安全問題而召回的支架削弱了患者對這些設備的有效性和安全性的信心。當患者和醫療保健提供者認為與支架相關的風險較高時，他們可能會選擇替代治療或方法，導致需求減少。多次召回往往會引起監管機構的注意，促使對支架製造和品質控制流程進行更嚴格的監督。雖然這對於患者安全至關重要，但它可能導致產品批准和市場推出的延遲，限制支架的可用性並減少需求。高調的召回可能會產生負面宣傳，從而進一步削弱大眾對支架產品的信任。這種看法會影響患者的決定並降低他們接受支架手術的意願，即使有醫學指徵。

支架行業的大量產品召回創造了一個充滿挑戰的環境，其特點是患者信任度下降、監管審查和競爭加劇。這些因素共同導致了支架手術和產品需求的減少，凸顯了嚴格的品質控制和安全措施對於維持支架製造商在醫療保健市場的信譽和生存能力的重要性。

主要市場趨勢

非侵入性手術選項

對微創手術和管理的需求不斷成長，顯著增加了對先進支架的需求，這對於支持和改善患者的治療效果至關重要。這些創新的醫療設備在提供有效的治療選擇且對身體的干擾最小化方面發揮著至關重要的作用。

微創手術已被證明對癒合過程非常有益，可以使患者更快康復並減少術後併發症。然而，值得注意的是，這些手術通常需要較長的持續時間才能確保最佳結果並促進完全康復。相較之下，非侵入性外科手術已成為患者（尤其是糖尿病患者）的一種有前途的替代方案。這些程序提供更快的癒合和恢復時間，使患者能夠更快地恢復健康和福祉。

醫療保健領域對現代技術的需求不斷成長，為支架市場的成長創造了絕佳的機會。隨著醫療保健提供者和患者都尋求先進的解決方案和改善的結果，全球對尖端支架的需求持續成長。這個不斷成長的市場呈現出巨大的創新和發展潛力，推動醫療保健行業加強患者護理並提高生活品質。

不健康的生活方式和久坐的習慣

由於現代生活方式和久坐習慣，人們的整體健康狀況嚴重惡化。患者心血管疾病的增加令人震驚，並且隨著時間的推移而迅速增加。為了解決這個關鍵問題，患有嚴重阻塞的患者需要使用先進的支架，不僅提供有效的治療，而且對市場的成長做出了重大貢獻。

此外，緊張的工作日程和忙碌的生活方式的普遍性對個人的心臟健康產生了深遠的影響。這一新興趨勢為支架市場的擴展和滿足對創新解決方案日益成長的需求提供了重大機會。透過滿足患者的特定需求並提供先進的支架技術，該市場可以在改善整體心臟健康和提高許多人的生活品質方面發揮至關重要的作用。

細分市場洞察

生物材料見解

根據生物材料，市場分為金屬生物材料、聚合物生物材料和天然生物材料。 2022年，金屬生物材料領域已成為市場的主導力量。隨著心血管疾病支架的生產成為重點，該行業的製造商正在積極加強。隨著內視鏡檢查和透視病例的增加，這些金屬支架的使用預計將出現顯著激增。

此外，預計聚合物生物材料領域的成長軌跡也將在未來幾年獲得成長動能。對聚合物支架的需求大幅上升，這主要是由於心血管疾病病例的不斷增加。此外，政府對此類支架的認可度不斷提高，進一步提振了市場前景，預示著該領域的廣闊前景。

最終使用者見解

根據最終用戶，醫院部分已成為最大的部分，因為大多數程序都是在醫院設置內進行的。醫院設施為患者和醫務人員提供廣泛的設施，為進行外科手術創造有利的環境。醫院擁有最先進的設備和專業的醫療保健專業人員團隊，可確保在這些手術過程中提供最高水準的護理和安全。

此外，在整個手術過程中密切監測患者的其他重要參數非常重要，這可以在設備齊全的醫院環境中有效地完成。這種持續監測有助於發現任何潛在的併發症或偏差，以便及時介入並確保患者獲得最佳結果。除醫院外，門診手術中心領域預計也將顯著成長。這些中心在門診提供專業手術服務，為患者提供便利和成本效益。隨著醫療技術的進步和對微創手術的需求不斷增加，門診手術中心正在成為醫療保健領域不可或缺的一部分。

總體而言，醫院內多種設施的可用性和門診手術中心的興起有助於手術治療的成長和擴大，確保患者在合適的醫療環境中獲得最高品質的照護。

區域洞察

根據地理分析，北美地區已成為最大的支架市場，因為該地區居住著大量患者。北美人口中有很大一部分屬於老年人，導致久坐的生活方式和心血管疾病發生率的增加。由於老年人癒合能力較弱，對微創外科手術的需求不斷成長，促進了支架市場的快速擴張。此外，現代生活方式和久坐習慣導致膽固醇水平上升，導致心腔發生嚴重阻塞，需要進行手術治療。醫院擁有最先進的醫療設施，進一步擴大了該地區的市場。

同樣，由於政府提供先進的醫療服務，歐洲地區的支架市場也不斷成長。歐洲人口對現代醫療保健服務的利用導致了對先進手術選擇和尖端設備使用的需求。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球支架市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型（藥物洗脫支架、裸金屬冠狀動脈支架及生物可吸收支架）
    • 依生物材料（金屬生物材料、高分子生物材料及天然生物材料）
    • 按最終使用者（醫院和診所、門診手術中心、其他）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章：北美支架市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 透過生物材料
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲支架市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 透過生物材料
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太支架市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 透過生物材料
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲支架市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 透過生物材料
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章 ：中東和非洲支架市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 透過生物材料
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非支架
    • 沙烏地阿拉伯支架
    • 阿拉伯聯合大公國支架

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球支架市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Medtronic plc
    • B. Braun Melsungen AG
    • Terumo Corporation
    • STENTYS SA
    • MicroPort Scientific Corporation
    • Meril Life Sciences Pvt. Ltd
    • Translumina GmbH
    • Biosensors International Group Limited
    • Boston Scientific Corporation
    • BIOTRONIK SE & Co. KG

第 16 章：策略建議

第 17 章：關於我們與免責聲明

簡介目錄
Product Code: 5006

The Global Stent Market, valued at USD 10.06 Billion in 2022, is poised for impressive growth in the forecast period, with an anticipated Compound Annual Growth Rate (CAGR) of 6.46% through 2028.

A stent is a small, mesh-like tube utilized to maintain the patency of narrowed or weakened passages within the body, such as arteries. It is commonly employed in the treatment of coronary arteries that have become narrowed, thereby reducing the supply of oxygen-rich blood to the heart. The procedure of placing a stent within the body is known as stenting.

One of the primary applications of stents is to restore blood flow in vessels that have become obstructed due to the accumulation of plaque. This plaque typically consists of substances like fat and cholesterol found in the bloodstream. Over time, this plaque adheres to the walls of the arteries, gradually diminishing the amount of oxygenated blood reaching various parts of the body. The buildup of plaque can lead to the development of coronary heart disease.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 10.06 Billion
Market Size 2028USD 14.77 Billion
CAGR 2023-20286.46%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

Individuals with plaque buildup may experience warning signs, such as chest pain. Without timely intervention, they face an increased risk of complications, including stroke or heart attack. To prevent arterial blockage or excessive narrowing, healthcare providers employ stents, which facilitate uninterrupted blood flow.

Stents come in various types, most commonly made from a mesh-like material of either plastic or metal. However, in larger arteries, stent grafts, composed of fabric, are used. Additionally, some stents are coated with medications to prevent the closure of the obstructed artery, promoting long-term patency.

Key Market Drivers

Increasing Prevalence of Chronic Diseases

The escalating prevalence of chronic diseases worldwide is significantly driving the demand for stents, a vital component of modern clinical therapeutics. Chronic conditions such as coronary artery disease, peripheral artery disease, and kidney diseases often result in the narrowing of blood vessels, obstructing the smooth flow of blood. Stents, small mesh tubes that are used to treat narrowed or weakened arteries in the body, present an effective solution to this problem.

The surge in cases of diabetes and obesity, primarily due to sedentary lifestyles and unhealthy eating habits, is contributing to an upswing in vascular diseases. This, in turn, is propelling the need for stenting procedures. Moreover, the aging population is increasingly susceptible to chronic diseases, adding to the impetus for stent demand.

In a bid to meet this burgeoning demand, medical device manufacturers are focusing on the development of advanced stents, characterized by improved designs, biocompatibility, and drug-eluting properties. The advancements in minimally invasive surgical procedures are also boosting the adoption of these devices. In light of these integral roles that stents play in responding to chronic diseases, it is anticipated that the demand of stents to continue on an upward trajectory. This makes stents a focal point in healthcare strategies globally, with a particular emphasis on enhancing their effectiveness, accessibility, and affordability.

Increasing Geriatric Population

As individuals age, their risk of developing cardiovascular diseases such as coronary artery disease (CAD) and peripheral arterial disease (PAD) significantly increases. Stents are a crucial medical device used to treat these conditions by reopening blocked or narrowed arteries, improving blood flow, and preventing serious complications like heart attacks and strokes. The elderly often contends with multiple chronic health conditions, including diabetes and hypertension, which can accelerate the development and progression of atherosclerosis. Stents are frequently employed to address the consequences of these conditions by maintaining the patency of blood vessels. Ongoing research and development in stent technology have led to the creation of more advanced and innovative devices. Drug-eluting stents, for instance, release medication to reduce the risk of restenosis or re-narrowing of the treated artery. These technological advancements have improved the efficacy and safety of stent procedures, making them more suitable for older patients.

Stent placement is typically performed through minimally invasive procedures, which are often preferred for older patients who may have additional health concerns. These procedures offer quicker recovery times and reduce post-operative complications compared to traditional open surgeries. The increasing geriatric population is a significant driver behind the rising demand for stents. As older individuals become more susceptible to cardiovascular diseases and other chronic health conditions, the need for interventional procedures like stent implantation is expected to grow. The development of innovative stent technologies and minimally invasive techniques further supports the utilization of stents in addressing the healthcare needs of the elderly, ultimately improving their overall quality of life and longevity.

Technological Advancements in Stent Development

The growing demand for advanced technology in the field of medical science and healthcare has led to a significant boost in the demand for stents in the market. With an increasing number of individuals from the geriatric age group requiring medical intervention, stents have become a crucial component in addressing their healthcare needs. Moreover, the availability of higher disposable income has empowered individuals to opt for cutting-edge technologies and equipment that provide superior outcomes following surgical procedures.

The utilization of these state-of-the-art technologies has instilled confidence in potential consumers, assuring them of the effectiveness and reliability of surgical procedures and techniques. This not only enhances patient satisfaction but also contributes to the overall growth of the stent market. Furthermore, the recent advancements witnessed in the wake of the pandemic outbreak, such as the development of innovative stent designs and materials, have further contributed to the expansion of the stent market.

These developments have created new opportunities for growth and innovation in this crucial medical field, paving the way for advancements in stent technology to meet the evolving needs of patients and healthcare providers alike. As the demand for advanced medical solutions continues to rise, the stent market is poised for further expansion and progress, playing a vital role in improving patient outcomes and enhancing the quality of healthcare.

Increasing Demand for Surgical Procedures

In recent years, there has been a noticeable and gradual increase in the demand for advanced surgical procedures that utilize minimally invasive techniques. These cutting-edge methods have revolutionized the field of surgery, providing patients with less invasive options and faster recovery times. One area that has particularly benefited from these advancements is cardiovascular surgery. The introduction of modern equipment and devices has greatly improved the success rates and outcomes of surgical procedures related to the cardiovascular system. In particular, the use of stents has become increasingly common, offering effective solutions for patients suffering from severe blockages caused by high cholesterol levels.

The demand for surgical interventions is further fueled by the preferences of the geriatric population. With limited time to wait for the effects of medications, many older patients opt for surgical procedures as a more immediate solution to their cardiovascular conditions. This growing demand for surgical interventions presents a significant opportunity for market growth in the forecast period. As the number of people worldwide suffering from severe cardiovascular diseases continues to rise, the market for advanced surgical procedures and related products is poised for long-term expansion. Overall, these trends highlight the need for continuous innovation in the field of minimally invasive surgery and the potential for significant advancements in patient care and outcomes.

Key Market Challenges

Unfavorable Government Regulations

The growth of the stent market has been significantly hindered by numerous rules and regulations that are directly associated with the development of modern technologies. These regulations, imposed by the government, have posed major challenges and obstacles to the market's expansion. The unfavorable government regulations and guidelines have not only affected the market in the short term but also have the potential to impede its growth in the long run.

One of the key areas where these obstacles have been experienced is in terms of insurance coverage. The regulations surrounding insurance coverage for stent procedures have made it difficult for common people to access and afford these modern technologies. Additionally, the burden of taxes further adds to the financial challenges faced by individuals seeking stent treatment. The stent market faces significant hurdles due to the complex web of regulations and guidelines imposed by the government. These barriers not only limit the growth potential of the market but also restrict the accessibility of modern technologies for those who could benefit from them.

High Product Recalls

Recalls of stents due to safety issues erode patient confidence in the effectiveness and safety of these devices. When patients and healthcare providers perceive a higher risk associated with stents, they may opt for alternative treatments or approaches, leading to reduced demand. Repeated recalls often attract the attention of regulatory authorities, prompting more rigorous oversight of stent manufacturing and quality control processes. While this is essential for patient safety, it can lead to delays in product approvals and market launches, limiting the availability of stents and reducing demand. High-profile recalls can generate negative publicity, which can further erode public trust in stent products. This perception can influence patients' decisions and reduce their willingness to undergo stent procedures, even when medically indicated.

High product recalls in the stent industry have created a challenging environment, characterized by decreased patient trust, regulatory scrutiny, and increased competition. These factors collectively contribute to the diminishing demand for stent procedures and products, underscoring the importance of rigorous quality control and safety measures to maintain the credibility and viability of stent manufacturers in the healthcare market.

Key Market Trends

Non-Invasive Procedures Options

The increasing demand for minimally invasive surgical procedures and management has significantly boosted the demand for advanced stents, which are crucial in supporting and enhancing patient outcomes. These innovative medical devices play a vital role in providing effective treatment options with minimal disruption to the body.

Minimally invasive surgical procedures have proven to be highly beneficial for the healing process, allowing patients to recover faster and experience reduced post-operative complications. However, it is worth noting that these procedures often require a longer duration to ensure optimal results and promote complete recovery. In contrast, non-invasive surgical procedures have emerged as a promising alternative for patients, particularly those with diabetes. These procedures offer faster healing and recovery times, empowering patients to regain their health and well-being more rapidly.

The increasing demand for modern technologies in the healthcare sector has created a remarkable opportunity for the growth of the stents market. With healthcare providers and patients alike seeking advanced solutions and improved outcomes, the demand for cutting-edge stents continues to rise globally. This growing market presents immense potential for innovation and development, driving the healthcare industry towards enhanced patient care and improved quality of life.

Unhealthy Lifestyle and Sedentary Habits

As a result of modern lifestyle practices and sedentary habits, the overall health of people has severely deteriorated. The rise in cardiovascular disorders among patients has been alarming, with a rapid increase over time. In order to address this critical issue, patients with major blockages require the utilization of advanced stents, which not only provide effective treatment but also contribute significantly to the growth of the market.

Furthermore, the prevalence of a stressful work schedule and busy lifestyle has had a profound impact on the cardiac health of individuals. This emerging trend presents a significant opportunity for the stent market to expand and cater to the increasing demand for innovative solutions. By addressing the specific needs of patients and offering advanced stent technologies, the market can play a vital role in improving overall cardiac health and enhancing the quality of life for many individuals.

Segmental Insights

Biomaterial Insights

Based on the biomaterial, the market is segmented into metallic biomaterial, polymeric biomaterial, and natural biomaterial. In 2022, the Metallic Biomaterial segment has emerged as the dominant force in the market. With a sharp focus on the production of stents for cardiovascular diseases, manufacturers in this industry are proactively increasing their efforts. The utilization of these metallic stents is projected to witness a notable surge alongside the rise in endoscopy and fluoroscopy cases.

Furthermore, the growth trajectory of the polymeric bio-materials segment is also anticipated to gain momentum in the upcoming years. The demand for polymeric stents has witnessed a significant upswing, largely driven by the escalating cases of cardiovascular diseases. Moreover, the government's increasing approval of this type of stent further bolsters market prospects, indicating a promising future for this segment.

End User Insights

Based on the end user, the segment of the hospital has emerged as the largest segment as most of the procedures are carried out within a hospital setup. A hospital setup provides a wide range of facilities to both patients and medical staff, creating a conducive environment for carrying out surgical procedures. With state-of-the-art equipment and a dedicated team of healthcare professionals, hospitals ensure the highest level of care and safety during these procedures.

Furthermore, it is extremely essential to closely monitor the other vital parameters of the patient throughout the procedure, which can be efficiently done within a well-equipped hospital setup. This constant monitoring helps in detecting any potential complications or deviations, allowing for timely intervention and ensuring the best possible outcomes for the patients. In addition to hospitals, the ambulatory surgical center segment is also expected to witness significant growth. These centers offer specialized surgical services on an outpatient basis, providing convenience and cost-effectiveness to patients. With advancements in medical technology and increasing demand for minimally invasive procedures, ambulatory surgical centers are becoming an integral part of the healthcare landscape.

Overall, the availability of multiple facilities within hospitals and the rise of ambulatory surgical centers contribute to the growth and expansion of surgical treatments, ensuring that patients receive the highest quality care in a suitable healthcare setting.

Regional Insights

Based on geographical analysis, the North America region has emerged as the largest market for stents, attributable to the substantial patient population residing in this area. A significant portion of the North American population falls within the geriatric age group, leading to sedentary lifestyles and an increased incidence of cardiovascular diseases. The growing demand for minimally invasive surgical procedures, fueled by the weak healing capacity of the geriatric population, has contributed to the rapid expansion of the stents market. Furthermore, the rising cholesterol levels resulting from modern lifestyle practices and sedentary habits have led to the occurrence of severe blockages in the heart's lumen, necessitating surgical management. The availability of state-of-the-art healthcare facilities in hospitals has further augmented the market in this region.

Similarly, the European region has witnessed a growing market for stents due to the advanced healthcare services provided by the government. The European population's utilization of modern healthcare services has led to a demand for advanced surgical options and the utilization of cutting-edge equipment.

Key Market Players

  • Medtronic plc
  • B. Braun Melsungen AG
  • Terumo Corporation
  • STENTYS SA
  • MicroPort Scientific Corporation
  • Meril Life Sciences Pvt. Ltd
  • Translumina GmbH
  • Biosensors International Group Limited
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG

Report Scope:

In this report, the Global Stent Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Stent Market, By Product Type:

  • Drug-Eluting Stent
  • Bare Metal Coronary Stent
  • Bioabsorbable Stent

Stent Market, By Biomaterial:

  • Metallic Biomaterial
  • Polymeric Biomaterial
  • Natural Biomaterial

Stent Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Surgical Centres
  • Others

Stent Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Stent Market.

Available Customizations:

  • Global Stent market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Stent Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Drug-Eluting Stent, Bare Metal Coronary Stent, and Bioabsorbable Stent)
    • 5.2.2. By Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, and Natural Biomaterial)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map

6. North America Stent Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Biomaterial
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Stent Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Biomaterial
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Stent Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Biomaterial
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Stent Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Biomaterial
        • 6.3.3.2.3. By End User

7. Europe Stent Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Biomaterial
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Stent Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Biomaterial
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Stent Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Biomaterial
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy Stent Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Biomaterial
        • 7.3.3.2.3. By End User
    • 7.3.4. France Stent Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Biomaterial
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Stent Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Biomaterial
        • 7.3.5.2.3. By End User

8. Asia-Pacific Stent Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Biomaterial
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Stent Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Biomaterial
        • 8.3.1.2.3. By End User
    • 8.3.2. India Stent Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Biomaterial
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Stent Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Biomaterial
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Stent Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Biomaterial
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Stent Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Biomaterial
        • 8.3.5.2.3. By End User

9. South America Stent Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Biomaterial
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Stent Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Biomaterial
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Stent Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Biomaterial
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Stent Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Biomaterial
        • 9.3.3.2.3. By End User

10. Middle East and Africa Stent Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Biomaterial
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Stent Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Biomaterial
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Stent Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Biomaterial
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Stent Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Biomaterial
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Stent Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Medtronic plc
    • 15.5.2. B. Braun Melsungen AG
    • 15.5.3. Terumo Corporation
    • 15.5.4. STENTYS SA
    • 15.5.5. MicroPort Scientific Corporation
    • 15.5.6. Meril Life Sciences Pvt. Ltd
    • 15.5.7. Translumina GmbH
    • 15.5.8. Biosensors International Group Limited
    • 15.5.9. Boston Scientific Corporation
    • 15.5.10. BIOTRONIK SE & Co. KG

16. Strategic Recommendations

17. About Us & Disclaimer